Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ELUT
ELUTIA INC
NASDAQ
$0.88
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$38.90 M
52w High$2.38
52w Low$0.50
Dividend Yield—
Frequency—
P/E-1.80
Volume138.62K
Shares Out.44.21M

COMPANY

LEADERSHIP

C. Randal Mills
CHIEF EXECUTIVE
C. Randal Mills

COMPENSATION 2026

Salary$600,000
Stock Awards$0
Incentive Plan Pay$738,000
All Other Comp.$6,284
Total$1,344,284

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 7, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
26

PRICE TARGET

Target High$10.50
Target Low$5.00
Target Median$10.00
Target Consensus$8.88

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$1.00M
NOV
12
THU

PRICE

$0.88 ▲ UP 0.00% (+$0.00)
$0.88$0.90$0.939:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.88

About Elutia Inc

https://elutia.com ↗

Elutia Inc. develops and commercializes drug-eluting biologics for neurostimulation, wound care, and breast reconstruction, serving hospitals with products like CanGaroo, ProxiCor, Tyke, VasCure, and SimpliDerm across device protection, women’s he...

INDUSTRY

Biotechnology

A PRODUCT ELUTIA INC IS KNOWN FOR

SimpliDerm
SimpliDerm

SimpliDerm, a hydrated human acellular dermal matrix for soft-tissue reconstruction, is Elutia’s flagship product, now its primary focus after selling its bioenvelope business to Boston Scientific.

COMPETITORS

COMPETITOR
ABBV COMPARE
IART COMPARE
MDXG COMPARE
ORGO COMPARE
SNN COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Womens Health$2.38M $2.12M ▼$2.09M ▼$1.28M ▼
Cardiovascular$944K $1.15M ▲$1.02M ▼$1.14M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 899.9K
IWC
0.01% · 118.7K

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings3
Price To Book3
Overall Score3

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Mills C Randal
Purchase · 22.5K shares
2026-06-21
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Mills C Randal
Sale · 8.1K shares
2026-06-21
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Mills C Randal
Sale · 22.5K shares
2026-06-21
★
DIRECTOR, 10 PERCENT OWNER:
RAKIN KEVIN
Purchase · 159.6K shares
2026-06-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Lake Street BUY

SECTORS PEERS

PEERPRICE
PYPD$5.07COMPARE
RNXT$1.67COMPARE
ANVS$1.72COMPARE
CELU$1.58COMPARE
LTRN$2.07COMPARE
TVRD$1.82COMPARE
CALC$0.46COMPARE
RVPH$0.52COMPARE